Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1076, pseudogene (RNU6-1076P) is a non-coding RNA gene annotated as a pseudogene of the U6 small nuclear RNA family. U6 small nuclear RNAs (snRNAs) are critical components of the spliceosome involved in pre-mRNA splicing in eukaryotic cells[3][1]. However, as a pseudogene, RNU6-1076P is predicted to be non-functional, arising from duplication or retrotransposition events that led to loss of coding or regulatory capability[2][5][7]. Pseudogenes of U6 snRNA are common in the human genome, and nearly all are presumed to be unexpressed and lack biological activity or therapeutic targeting significance. There is no evidence that RNU6-1076P is transcribed or functional in splicing or any other cellular process[2][5][7]. RNU6-1076P is not a therapeutic target, does not encode a protein, and has no established role in health or disease[7]. No drugs, biomarkers, or safety concerns are associated with this pseudogene. The canonical form reflects gene nomenclature conventions for human snRNA pseudogenes, and there is no evidence of pathophysiological relevance or pharmacological modulation[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1076, pseudogene (RNU6-1076P).